Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.120 | None | 0.750 | 2 | 1 | 1997 | 2017 | ||||||||
|
ZFP90 zinc finger protein | 0.780 | 0.231 | 3.2E-02 |
|
disease | 0.110 | None | 0.800 | 4 | 2 | 2009 | 2017 | ||||||||
|
immunity related GTPase M | 0.617 | 0.538 |
|
disease | 0.450 | None | 0.875 | 2 | 2 | 2009 | 2016 | |||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.170 | None | 0.875 | 1 | 1 | 1998 | 2017 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.170 | None | 0.875 | 1 | 1 | 2007 | 2015 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.885 | 1 | 1 | 1993 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.200 | None | 0.889 | 3 | 2 | 1998 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.180 | None | 0.889 | 1 | 1 | 2010 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.700 | None | 0.909 | 1 | 3 | 1998 | 2019 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.200 | None | 0.953 | 1 | 1 | 2004 | 2020 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
disease | 0.500 | None | 0.960 | 3 | 2 | 2004 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.500 | None | 0.968 | 3 | 1 | 1995 | 2020 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.982 | 9 | 10 | 2006 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 7 | 4 | 2008 | 2011 | |||||||||
|
IFNG antisense RNA 1 | 0.659 | 0.654 |
|
disease | 0.110 | None | 1.000 | 6 | 5 | 2009 | 2017 | |||||||||
|
long intergenic non-protein coding RNA 1620 | 0.805 | 0.269 | 0.45 |
|
disease | 0.100 | None | 1.000 | 6 | 2 | 2009 | 2017 | ||||||||
|
caspase recruitment domain family member 9 | 0.566 | 0.654 | 8.1E-13 |
|
disease | 0.430 | None | 1.000 | 6 | 5 | 2008 | 2017 | ||||||||
|
G protein subunit alpha 12 | 0.547 | 0.769 | 0.97 |
|
disease | 0.410 | None | 1.000 | 5 | 2 | 2011 | 2017 | ||||||||
|
macrophage stimulating 1 | 0.465 | 0.885 | 4.8E-19 |
|
disease | 0.470 | None | 1.000 | 5 | 1 | 2008 | 2017 | ||||||||
|
pseudouridine synthase 10 | 0.736 | 0.346 | 7.9E-14 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2010 | 2017 | ||||||||
|
innate immunity activator | 0.743 | 0.346 | 2.2E-04 |
|
disease | 0.100 | None | 1.000 | 5 | 2 | 2009 | 2017 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.130 | None | 1.000 | 4 | 3 | 2011 | 2019 | ||||||||
|
chromosome 1 open reading frame 141 | 0.691 | 0.385 | 3.2E-03 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2010 | 2016 | ||||||||
|
long intergenic non-protein coding RNA 598 | 0.743 | 0.192 |
|
disease | 0.100 | None | 1.000 | 4 | 1 | 2011 | 2017 | |||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2011 | 2017 |